CN105806967B - The analysis method of key ezetimibe intermediate 4 [[(4 fluorophenyl) imines] methyl] phenol - Google Patents

The analysis method of key ezetimibe intermediate 4 [[(4 fluorophenyl) imines] methyl] phenol Download PDF

Info

Publication number
CN105806967B
CN105806967B CN201410844917.XA CN201410844917A CN105806967B CN 105806967 B CN105806967 B CN 105806967B CN 201410844917 A CN201410844917 A CN 201410844917A CN 105806967 B CN105806967 B CN 105806967B
Authority
CN
China
Prior art keywords
imines
methyl
analysis method
phenol
impurity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410844917.XA
Other languages
Chinese (zh)
Other versions
CN105806967A (en
Inventor
卢生杰
陈敏
高曙光
汤丹
袁永玲
左联
卢智俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LANGSHENG PHARMACEUTICAL CO Ltd GUANGZHOU CITY
Original Assignee
LANGSHENG PHARMACEUTICAL CO Ltd GUANGZHOU CITY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LANGSHENG PHARMACEUTICAL CO Ltd GUANGZHOU CITY filed Critical LANGSHENG PHARMACEUTICAL CO Ltd GUANGZHOU CITY
Priority to CN201410844917.XA priority Critical patent/CN105806967B/en
Publication of CN105806967A publication Critical patent/CN105806967A/en
Application granted granted Critical
Publication of CN105806967B publication Critical patent/CN105806967B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

The invention discloses the analyzing detecting method of a kind of key intermediate 4 of Ezetimibe [[(4 fluorophenyl) imines] methyl] phenol and its application, this method to use silica gel bonded cellulose iii(3,5 dichlorophenyl carbamates)Chiral chromatographic column carries out analysis detection to 4 [[(4 fluorophenyl) imines] methyl] phenol, being capable of monitoring objective emphasis impurity well:Chloro impurity, defluorinate impurity and a fluorine impurity, and it is simple and convenient, specificity is strong, is suitable for daily use in 4 [[(4 fluorophenyl) imines] methyl] the relevant materials of phenol and content detection.

Description

Point of key ezetimibe intermediate 4- [[(4- fluorophenyls) imines] methyl]-phenol Analysis method
Technical field
The invention belongs to analysis technical field, and in particular to [[(4- fluorophenyls) is sub- by a kind of key ezetimibe intermediate 4- Amine] methyl]-phenol analyzing detecting method and its application.
Background technology
4- [[(4- fluorophenyls) imines] methyl]-phenol is the key intermediate of Ezetimibe synthesis, and Ezetimibe is choosing Selecting property cholesterol absorption inhibitor, is clinically widely used.4- [[(4- fluorophenyls) imines] methyl]-phenol contains 3 impurity-chloro impurity, defluorinate impurity and a fluorine impurity can participate in reaction and take in finished product, influence finished product purity and Yield, therefore above-mentioned impurity preferably controls in initiation material.
4- [[(4- fluorophenyls) imines] methyl]-phenol, CAS:3382-63-6
Chloro impurityDefluorinate impurity Between fluorine impurity
Existing 4- [[(4- fluorophenyls) imines] methyl]-phenol method for detecting purity is target nuclear magnetic resonance method in adding (Enterprise of An Run Pharmaceutical Technology Co., Ltd internal control method), this method can not survey to each impurity range go-on-go, and accuracy is low, and nuclear-magnetism The use of resonance instrument is not yet common, and method is cumbersome.At present, also without the analysis for the compound in domestic and international open source literature Method is reported.
The content of the invention
In order to solve the above technical problems, a kind of application of present invention offer it is convenient, accurately and reliably, specificity it is strong-[[(4- Fluorophenyl) imines] methyl] and-phenol analyzing detecting method, methods described is high performance liquid chromatography, and its chromatographic condition is:Adopt With silica gel bonded cellulose-three(3,5- dichlorophenyl carbamates)The mixing of chiral chromatographic column, n-hexane and isopropanol is molten Agent is mobile phase, and wherein n-hexane and isopropanol volume ratio are 96 ~ 99:4 ~ 1, and detected using UV-detector, flow Speed is 0.5 ~ 2.0 ml/min, and the column temperature of chromatographic column is 15 ~ 40 DEG C.
Above-mentioned detection method, silica gel bonded cellulose-three(3,5- dichlorophenyl carbamates)Chiral chromatographic column is optional For Daicel Chiralpak IC columns.
Above-mentioned detection method, silica gel bonded cellulose-three(3,5- dichlorophenyl carbamates)The rule of chiral chromatographic column Lattice may be selected 150 x 4mm, 5 μm or 250 x 4mm, 5 μm.
The volume ratio of above-mentioned detection method, wherein n-hexane and isopropanol is chosen as 98:2.
Above-mentioned detection method, the Detection wavelength of UV-detector are chosen as 284 nm.
Above-mentioned detection method, flow velocity are chosen as 1.0ml/min.
Above-mentioned detection method, the column temperature of chromatographic column are chosen as 35 DEG C.
Above-mentioned detection method, it can be applied to the relevant material detection of 4- [[(4- fluorophenyls) imines] methyl]-phenol and contain It is fixed to measure.
4- [[(4- fluorophenyls) imines] methyl]-phenol contains imine structure, meets water decomposition for para-fluoroaniline and to hydroxyl first Aldehyde,
Can not Direct Analysis using reversed-phase liquid chromatography.Such as using will unstable compound destroy or derivatization after enter again Row analysis method, operation it is more complicated, and compare be difficult to ensure demonstrate,prove its compound degraded completely or its degradation pathway tolerance, There are certain difficulty and risk in terms of impurity monitoring;And need the otherness of checked for impurities small, it is difficult using the positive post separation of routine To reach preferable effect.Use silica gel bonded cellulose-three(3,5- dichlorophenyl carbamates)Chiral chromatographic column is carried out Analysis detection, unexpectedly achieves unexpected good result, and each impurity is successfully separated, being capable of monitoring objective weight well Point impurity, and it is simple and convenient, it is suitable for daily use.
Brief description of the drawings
Fig. 1 is that impurity reference substance HPLC schemes in embodiment 1;
Fig. 2 is that 4- [[(4- fluorophenyls) imines] methyl]-phenol HPLC schemes in embodiment 1;
Fig. 3 is the HPLC figures that impurity mixes with 4- [[(4- fluorophenyls) imines] methyl]-phenol in embodiment 1.
Embodiment
The above of the present invention is described in further detail again below by way of specific embodiment.But this should not be managed The scope solved as the above-mentioned theme of the present invention is limited only to following example.The situation of the above-mentioned technological thought of the present invention is not being departed from Under, the various replacements or change made according to ordinary skill knowledge and customary means, model of the invention all should be included in In enclosing.
Embodiment 1
Instrument and condition
Instrument:Shimadzu LC-20A high performance liquid chromatographs, electronic analytical balance
Chromatographic column:Daice lChiralpak IC columns 150 x 4.6mm,5μm
Column temperature:35℃
Ultraviolet detection wavelength:284nm
Mobile phase:N-hexane:Isopropanol 98:2
Flow velocity:1.0ml/min
Test procedure
Configure impurity reference substance storing solution:Take para-fluoroaniline, to hydroxy carbaldehyde, go fluorine, defluorinate, a fluorine impurity each about 10mg, it is placed in 100ml volumetric flasks, uses isopropanol:N-hexane(10:90)Dissolve and be diluted to scale, shake up, produce;
Configure impurity reference substance solution:Precision pipettes reference substance storing solution 1.0ml and put in 10ml volumetric flasks, isopropanol:Just Hexane(10:90)Dissolve and be diluted to scale, shake up, produce;
Configure 4- [[(4- fluorophenyls) imines] methyl]-phenol solution:Take 4- [[(4- fluorophenyls) imines] methyl]-phenol 10mg is put in 20ml volumetric flasks, uses isopropanol:N-hexane(10:90)Dissolve and be diluted to scale, shake up, produce.
Configure impurity and 4- [[(4- fluorophenyls) imines] methyl]-phenol mixed solution:Test sample 10mg is taken to put 20ml appearances In measuring bottle, with a small amount of isopropanol:N-hexane(10:90)Dissolving, pipettes 2.0ml reference substance storing solutions and puts in volumetric flask, use isopropyl Alcohol:N-hexane(10:90)Scale is diluted to, is shaken up, is produced;
Impurity reference substance solution, 4- [[(4- fluorophenyls) imines] methyl]-phenol solutions and impurity and 4- [[(4- are taken respectively Fluorophenyl) imines] methyl] 10 μ l of-phenol mixed solution, high-efficient liquid phase analysis are carried out by above-mentioned condition, record chromatogram respectively (Accompanying drawing 1,2,3).
Result of the test
Conclusion:In analyte detection process, 4- [[(4- fluorophenyls) imines] methyl]-phenol is undegraded;Its with it is each to be measured miscellaneous Can baseline separation between matter, each impurity to be measured.
Embodiment 2
Instrument and condition
Instrument:Shimadzu LC-20A high performance liquid chromatographs, electronic analytical balance
Chromatographic column:Daicel Chiralpak IC columns 250 x 4.6mm,5μm
Column temperature:20℃
Ultraviolet detection wavelength:284nm
Mobile phase:N-hexane:Isopropanol 96:4
Flow velocity:1.0ml/min
Test procedure
The μ l of 4- [[(4- fluorophenyls) imines] methyl]-phenol mixed solution 10 that Example 1 configures, are entered by above-mentioned condition Row high-efficient liquid phase analysis, record chromatogram.
Result of the test
Conclusion:4- [[(4- fluorophenyls) imines] methyl] can baseline between-phenol and each impurity to be measured, each impurity to be measured Separation.
Embodiment 3
Instrument and condition
Instrument:Shimadzu LC-20A high performance liquid chromatographs, electronic analytical balance
Chromatographic column:Daicel Chiralpak IC columns 150 x 2.1mm,5μm
Column temperature:40℃
Ultraviolet detection wavelength:275nm
Mobile phase:N-hexane:Isopropanol 99:1
Flow velocity:0.5ml/min
Test procedure
The μ l of 4- [[(4- fluorophenyls) imines] methyl]-phenol mixed solution 10 that Example 1 configures, are entered by above-mentioned condition Row high-efficient liquid phase analysis, record chromatogram.
Result of the test
Conclusion:4- [[(4- fluorophenyls) imines] methyl] can baseline between-phenol and each impurity to be measured, each impurity to be measured Separation.
Embodiment 4
Instrument and condition
Instrument:Shimadzu LC-20A high performance liquid chromatographs, electronic analytical balance
Chromatographic column:Daicel Chiralpak IC columns 250 x 4.6mm,5μm
Column temperature:30℃
Ultraviolet detection wavelength:284nm
Mobile phase:N-hexane:Isopropanol 97:3
Flow velocity:2.0ml/min
Test procedure
The μ l of 4- [[(4- fluorophenyls) imines] methyl]-phenol mixed solution 10 that Example 1 configures, are entered by above-mentioned condition Row high-efficient liquid phase analysis, record chromatogram.
Result of the test
Conclusion:4- [[(4- fluorophenyls) imines] methyl] can baseline between-phenol and each impurity to be measured, each impurity to be measured Separation.

Claims (9)

1. a kind of analysis method of key ezetimibe intermediate 4- [[(4- fluorophenyls) imines] methyl]-phenol, methods described For high performance liquid chromatography, it is characterised in that this method includes using silica gel bonded cellulose-three(3,5- dichlorophenyl amino Formic acid esters)The mixed solvent of chiral chromatographic column, n-hexane and isopropanol is mobile phase, and wherein n-hexane and isopropanol volume ratio is 96~99:4 ~ 1, and detected using UV-detector, flow velocity is 0.5 ~ 2.0ml/min, and the column temperature of chromatographic column is 15 ~ 40 DEG C.
2. analysis method according to claim 1, it is characterised in that:The silica gel bonded cellulose-three(3,5- dichloro-benzenes Aminocarbamic acid ester)Chiral chromatographic column is Daicel Chiralpak IC columns.
3. analysis method according to claim 1, it is characterised in that:The silica gel bonded cellulose-three(3,5- dichloro-benzenes Aminocarbamic acid ester)The specification of chiral chromatographic column is 150x4.6mm, 5 μm or 250x4.6mm, 5 μm.
4. analysis method according to claim 1, it is characterised in that:The volume ratio of the n-hexane and isopropanol is 98: 2。
5. analysis method according to claim 1, it is characterised in that:The Detection wavelength of described UV-detector is 284nm。
6. analysis method according to claim 1, it is characterised in that:The flow velocity is 1.0ml/min.
7. analysis method according to claim 1, it is characterised in that:The column temperature of the chromatographic column is 35 DEG C.
8. the analysis method described in claim any one of 1-7, it is in 4- [[(4- fluorophenyls) imines] methyl] the relevant thing of-phenol Application in quality detection.
9. the analysis method described in claim any one of 1-7, it is examined in 4- [[(4- fluorophenyls) imines] methyl]-phenol content Application in survey.
CN201410844917.XA 2014-12-31 2014-12-31 The analysis method of key ezetimibe intermediate 4 [[(4 fluorophenyl) imines] methyl] phenol Active CN105806967B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410844917.XA CN105806967B (en) 2014-12-31 2014-12-31 The analysis method of key ezetimibe intermediate 4 [[(4 fluorophenyl) imines] methyl] phenol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410844917.XA CN105806967B (en) 2014-12-31 2014-12-31 The analysis method of key ezetimibe intermediate 4 [[(4 fluorophenyl) imines] methyl] phenol

Publications (2)

Publication Number Publication Date
CN105806967A CN105806967A (en) 2016-07-27
CN105806967B true CN105806967B (en) 2018-02-06

Family

ID=56420137

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410844917.XA Active CN105806967B (en) 2014-12-31 2014-12-31 The analysis method of key ezetimibe intermediate 4 [[(4 fluorophenyl) imines] methyl] phenol

Country Status (1)

Country Link
CN (1) CN105806967B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107677753B (en) * 2017-11-24 2021-03-16 中山奕安泰医药科技有限公司 Detection method of ezetimibe intermediate

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090209492A1 (en) * 2004-11-12 2009-08-20 Trustees Of Tufts College Lipase Inhibitors
CN103207248A (en) * 2012-12-21 2013-07-17 北京万全德众医药生物技术有限公司 Method of separating optical isomers of ezetimibe intermediate by using HPLC
CN103760281A (en) * 2014-01-14 2014-04-30 北京万全德众医药生物技术有限公司 Method for separating ezetimibe optical isomer by liquid-phase process
CN103760282A (en) * 2014-01-14 2014-04-30 北京万全德众医药生物技术有限公司 Method for separating and measuring ezetimibe intermediate related substances by liquid chromatography
CN104230978A (en) * 2014-09-22 2014-12-24 上海现代制药股份有限公司 Preparation midbody for Ezetimibe and preparation method of preparation midbody

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090209492A1 (en) * 2004-11-12 2009-08-20 Trustees Of Tufts College Lipase Inhibitors
CN103207248A (en) * 2012-12-21 2013-07-17 北京万全德众医药生物技术有限公司 Method of separating optical isomers of ezetimibe intermediate by using HPLC
CN103760281A (en) * 2014-01-14 2014-04-30 北京万全德众医药生物技术有限公司 Method for separating ezetimibe optical isomer by liquid-phase process
CN103760282A (en) * 2014-01-14 2014-04-30 北京万全德众医药生物技术有限公司 Method for separating and measuring ezetimibe intermediate related substances by liquid chromatography
CN104230978A (en) * 2014-09-22 2014-12-24 上海现代制药股份有限公司 Preparation midbody for Ezetimibe and preparation method of preparation midbody

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Development and Validation of Chiral HPLC Method for Identification and Quantification of (R)-Enantiomer in Ezetimibe;Kameswara Rao Chimalakonda 等;《American Journal of Analytical Chemistry》;20120731;第3卷;第479页的2.2-2.4 *
Isolation and Characterization of R-Enantiomer in Ezetimibe;Kameswara Rao Chimalakonda 等;《American Journal of Analytical Chemistry》;20130930;第4卷;第488-495页 *
RP-HPLC测定依折麦布原料药中的有关物质;周增慧 等;《中国实验方剂学杂志》;20131031;第19卷(第19期);第159-163页 *

Also Published As

Publication number Publication date
CN105806967A (en) 2016-07-27

Similar Documents

Publication Publication Date Title
Mane Racemic drug resolution: a comprehensive guide
NL Batista et al. Enantiomeric mixtures in natural product chemistry: separation and absolute configuration assignment
Ribeiro et al. Enantioseparation of chiral pharmaceuticals in biomedical and environmental analyses by liquid chromatography: An overview
Gavioli et al. Preparative enantiomer separation of dichlorprop with a cinchona-derived chiral selector employing centrifugal partition chromatography and high-performance liquid chromatography: a comparative study
Stavrou et al. Chiral selectors in CE: Recent development and applications (mid‐2014 to mid‐2016)
CN107941936B (en) Method for separating and determining rivaroxaban and impurities thereof and application
Choi et al. Single-drop microextraction in bioanalysis
de Koster et al. Past, present, and future developments in enantioselective analysis using capillary electromigration techniques
Han et al. Enantioseparation of aromatic α-hydroxycarboxylic acids: The application of a dinuclear Cu2 (II)-β-cyclodextrin complex as a chiral selector in high speed counter-current chromatography compared with native β-cyclodextrin
Wuethrich et al. Chiral capillary electromigration techniques—mass spectrometry—hope and promise
CN110849980A (en) Method for detecting content of enantiomer in isopropyl L-alanine
CN101701942A (en) Method for separating and measuring entecavir and optical isomer thereof by liquid chromatography
CN105675733B (en) method for separating and measuring trelagliptin succinate and optical isomers thereof by liquid chromatography
CN105806967B (en) The analysis method of key ezetimibe intermediate 4 [[(4 fluorophenyl) imines] methyl] phenol
Mazzoccanti et al. A perspective on enantioselective chromatography by comparing ultra-high performance supercritical fluid chromatography and normal-phase liquid chromatography through the use of a Pirkle-type stationary phase
CN106706769B (en) Separation and determination method of empagliflozin and optical isomer thereof
Vanthuyne et al. Chiroptical detectors for the study of unusual phenomena in chiral chromatography
CN105572252A (en) Method for analyzing/separating ezetimibe (R, R, S) type optical isomer
Wang et al. Detection of two genotoxic impurities in drug substance and preparation of imatinib mesylate by LC–MS/MS
CN104458945A (en) Separation and measurement method of besifloxacin hydrochloride and isomer of besifloxacin hydrochloride
Mukherjee et al. Importance of chirality and chiral chromatography in pharmaceutical industry: a detailed study
CN108226349B (en) Detection method for simultaneously determining multiple bacteriostatic agents in tramadol cream
CN110095554B (en) Method for analyzing milrinone related substances by high performance liquid chromatography
CN109085255B (en) Method for analyzing and preparing 3- (N-p-toluenesulfonyl-L-alanyloxy) -5-phenylpyrrole and enantiomer thereof by using HPLC method
CN110940740B (en) Detection method of L-alpha-glycerophosphorylcholine isomer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant